Benzylpenicillin (Penicillin G)
Brand names: Crystapen
Benzylpenicillin (penicillin G) is a parenteral narrow-spectrum beta-lactam given by intravenous or intramuscular injection for serious streptococcal, meningococcal and other susceptible infections, including severe ENT and deep neck-space infections.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins, and is bactericidal against susceptible Gram-positive cocci such as group A streptococci.
Prescribing in practice
- Contraindicated in patients with previous immediate hypersensitivity to penicillins; check allergy status carefully and have anaphylaxis management available, as serious reactions can occur with parenteral dosing.
- It is acid-labile and not absorbed orally, so it must be given by injection; doses are reduced in significant renal impairment because it is renally cleared.
- Very high parenteral doses contribute a notable sodium and potassium load and have rarely been associated with neurotoxicity (seizures), particularly in renal impairment.
Monitoring
Monitor renal function, electrolytes and clinical response, and observe for hypersensitivity, especially after the first parenteral dose.
Counselling the patient
- Tell staff at once about any rash, swelling, wheeze or faintness during or after the injection.
- Report any previous reaction to penicillin or other antibiotics before treatment.
- Complete the full prescribed course as directed.
Evidence & guidelines
Penicillin G remains a first-line agent for invasive group A streptococcal and meningococcal disease in national antimicrobial and infection guidance.
Reference: NICE NG84; ENT-UK Mastoiditis Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Centor/McIsaac Score (Pharyngitis) · Throat Infections
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- PID Severity (CDC Diagnostic Criteria) · Gynaecological Infections
- Gustilo-Anderson Classification (Open Fractures) · Fracture Classification
- Adult Upper Airway Obstruction (Stridor) · DAS 2015 unanticipated difficult airway; RCEM
- Epistaxis Management · ENT-UK / NICE
- Acute Otitis Media · NICE NG91 2018
- Tonsillitis and Sore Throat · NICE NG84 2018
- Benign Paroxysmal Positional Vertigo · NICE CG124 / AAO-HNS Guidelines
- Acute Rhinosinusitis · NICE NG79 2017 / EPOS 2020